These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14996719)

  • 21. Activator protein 2alpha status determines the chemosensitivity of cancer cells: implications in cancer chemotherapy.
    Wajapeyee N; Raut CG; Somasundaram K
    Cancer Res; 2005 Oct; 65(19):8628-34. PubMed ID: 16204029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
    Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
    Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
    Ruiz M; Troncoso P; Bruns C; Bar-Eli M
    Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAX6 methylation and ectopic expression in human tumor cells.
    Salem CE; Markl ID; Bender CM; Gonzales FA; Jones PA; Liang G
    Int J Cancer; 2000 Jul; 87(2):179-85. PubMed ID: 10861471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers.
    Palmisano WA; Crume KP; Grimes MJ; Winters SA; Toyota M; Esteller M; Joste N; Baylin SB; Belinsky SA
    Cancer Res; 2003 Aug; 63(15):4620-5. PubMed ID: 12907641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
    Zhang X; Leung YK; Ho SM
    Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation of the Wilms' tumor suppressor gene CpG island in human breast carcinomas.
    Laux DE; Curran EM; Welshons WV; Lubahn DB; Huang TH
    Breast Cancer Res Treat; 1999 Jul; 56(1):35-43. PubMed ID: 10517341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
    Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
    Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.
    Zhang X; Sun Q; Shan M; Niu M; Liu T; Xia B; Liang X; Wei W; Sun S; Zhang Y; Liu XS; Song Q; Yang Y; Ma Y; Liu Y; Yang L; Ren Y; Zhang G; Pang D
    PLoS One; 2013; 8(1):e53931. PubMed ID: 23349767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
    Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
    Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.
    Tommasi S; Karm DL; Wu X; Yen Y; Pfeifer GP
    Breast Cancer Res; 2009; 11(1):R14. PubMed ID: 19250546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
    Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
    Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Jun; 110(2):212-8. PubMed ID: 15069684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer.
    Gee JM; Robertson JF; Ellis IO; Nicholson RI; Hurst HC
    J Pathol; 1999 Dec; 189(4):514-20. PubMed ID: 10629551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.